The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GNC-038, a tetra-specific antibody, in patients with R/R non-Hodgkin lymphoma or acute lymphoblastic leukemia: A phase 1 study design and rationale.
 
Jianxiang Wang
Consulting or Advisory Role - Abbvie
 
Junyuan Qi
No Relationships to Disclose
 
Wenyu Li
No Relationships to Disclose
 
Zhimin Zhai
No Relationships to Disclose
 
Ping Li
No Relationships to Disclose
 
Wen Zou
Employment - Baili Biopharmaceutical
 
Muran Ding
Employment - Baili Biopharmaceutical; Baili Biopharmaceutical
 
Xue Yang
Employment - Baili Biopharmaceutical
 
Rong Wang
Employment - Baili Biopharmaceutical; Baili Biopharmaceutical
 
Wanjing Guo
Employment - Baili Biopharmaceutical; Baili Biopharmaceutical
 
Sa Xiao
Employment - Baili Biopharmaceutical
Stock and Other Ownership Interests - Baili Biopharmaceutical
 
Jahan S. Khalili
Employment - SystImmune
Stock and Other Ownership Interests - SystImmune
 
Hai Zhu
Employment - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
Leadership - Baili Biopharmaceutical (I); Systimmune (I)
Stock and Other Ownership Interests - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
 
Martin Sebastian Olivo
Employment - Gilead Sciences; Protara Therapeutics; Systimmune
Leadership - Protara Therapeutics; Systimmune
Stock and Other Ownership Interests - Gilead Sciences; Protara Therapeutics; SystImmune
(OPTIONAL) Uncompensated Relationships - Phoenix Molecular Designs
 
Yi Zhu
Employment - Baili Biopharmaceutical; SystImmune; Systimmune (I)
Leadership - Baili Biopharmaceutical; SystImmune
Stock and Other Ownership Interests - Baili Biopharmaceutical; SystImmune; SystImmune (I)